by Monya Baker
FEATURE	Can Biomarker Initiatives Stay on Target? Collaboration seems the way forward, if only pharma can pull it off Email: Monya Baker - mbaker@the-scientist.com The Scientist 2005, 19(18):14 Published   26 September 2005

With broader biomarker applications in their sights, pharmaceutical companies and academics are striving to collaborate, the lead story(below) in our feature on biomarkers reports. Nobel laureate Lee Hartwell explains what the fruit of such collaborations could be in hisVision. And those involved with mass spectrometrydebatehow powerful this discovery engine really is.

(continued >>)

To continue reading this full article, you must be a subscriber to The Scientist.

You are only a few minutes away from unlimited access.

If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.

Subscribe to The Scientist to get unlimited access to our premium content

Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95.  Subscribe now.

The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.